(19)
(11) EP 4 680 244 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24714142.7

(22) Date of filing: 18.03.2024
(51) International Patent Classification (IPC): 
A61K 31/517(2006.01)
A61K 9/00(2006.01)
A61P 39/00(2006.01)
 A61K 31/485(2006.01)
A61P 21/02(2006.01)
A61P 39/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/517; A61K 31/485; A61P 39/02; A61P 39/00; A61P 21/02
 
C-Sets:
  1. A61K 31/517, A61K 2300/00;
  2. A61K 31/485, A61K 2300/00;
(86) International application number:
PCT/EP2024/057173
(87) International publication number:
WO 2024/194263 (26.09.2024 Gazette 2024/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 17.03.2023 GB 202303948

(71) Applicant: Norwegian University Of Life Sciences
1430 As (NO)

(72) Inventors:
  • DIGRANES, Nora
    1432 Ås (NO)
  • HAGA, Henning Andreas
    1432 Ås (NO)
  • NORDGREEN, Janicke
    1432 Ås (NO)
  • LERVIK, Andreas
    1432 Ås (NO)

(74) Representative: Dehns 
10 Old Bailey
London EC4M 7NG
London EC4M 7NG (GB)

   


(54) SEROTONIN 5HT2A RECEPTOR ANTAGONIST FOR USE IN TREATING SIDE EFFECTS RESULTING FORM MU OPIOID RECEPTOR AGONIST OVERDOSE